Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches.
作者信息
Corbett Anne, Ballard Clive
机构信息
Wolfson Centre for Age-Related Diseases, King's College London, London, UK.
出版信息
Evid Based Med. 2016 Feb;21(1):25. doi: 10.1136/ebmed-2015-110324. Epub 2015 Dec 23.
PMID:26701197
Abstract
摘要
相似文献
1
Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches.右美沙芬和奎尼丁适用于在一线非药物治疗方法之后对患有阿尔茨海默病的人的激越症状进行短期的超说明书用药治疗。
Evid Based Med. 2016 Feb;21(1):25. doi: 10.1136/ebmed-2015-110324. Epub 2015 Dec 23.
2
Dextromethorphan-Quinidine for Agitation in Alzheimer Disease.右美沙芬-奎尼丁用于治疗阿尔茨海默病的激越症状
JAMA. 2016 Mar 15;315(11):1166. doi: 10.1001/jama.2015.18286.
3
Combination drug shows promise for treating agitation in patients with Alzheimer's disease.联合用药有望治疗阿尔茨海默病患者的激越症状。
BMJ. 2015 Sep 22;351:h5015. doi: 10.1136/bmj.h5015.
4
Dextromethorphan-Quinidine for Agitation in Alzheimer Disease--Reply.右美沙芬-奎尼丁用于治疗阿尔茨海默病的激越——回复
JAMA. 2016 Mar 15;315(11):1166-7. doi: 10.1001/jama.2015.18289.
5
Dextromethorphan and Quinidine for Treating Agitation in Patients With Alzheimer Disease Dementia.右美沙芬与奎尼丁治疗阿尔茨海默病痴呆患者的激越症状
JAMA. 2015;314(12):1233-5. doi: 10.1001/jama.2015.10215.
6
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.右美沙芬-奎尼丁对阿尔茨海默病痴呆患者激越的影响：一项随机临床试验。
JAMA. 2015;314(12):1242-54. doi: 10.1001/jama.2015.10214.
7
AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.AVP-786用于治疗阿尔茨海默病型痴呆的激越症状。
Expert Opin Investig Drugs. 2017 Jan;26(1):121-132. doi: 10.1080/13543784.2017.1267726. Epub 2016 Dec 11.
8
Advancements in the treatment of agitation in Alzheimer's disease.阿尔茨海默病激越治疗的进展
Expert Opin Pharmacother. 2015;16(11):1649-56. doi: 10.1517/14656566.2015.1059422.
9
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.治疗痴呆激越的药物治疗：系统评价和网络荟萃分析。
Br J Clin Pharmacol. 2018 Jul;84(7):1445-1456. doi: 10.1111/bcp.13604. Epub 2018 May 14.
10
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.治疗激越的进展：阿尔茨海默病中的一项重大临床挑战。
Expert Opin Pharmacother. 2015;16(17):2581-8. doi: 10.1517/14656566.2015.1092520. Epub 2015 Sep 21.
Zotero 插件